Breaking News Instant updates and real-time market news.

2020-10-12 12:42:53 SWGAY Swatch Group $0.00 / + (+0.00%) 12:42 10/12/20 10/12 12:42 10/12/20 12:42	Swatch inventory risk 'not as bad as it looks,' says Credit Suisse Credit Suisse analyst Guillaume Gauville reiterated an Outperform rating and CHF 280 price target on Swatch Group, saying the company's inventory risk is "not as bad as it looks." The analyst said he remains more constructive than the market on demand recovery, cost control, and inventory position.
SWGAY Swatch Group $0.00 / + (+0.00%) 10/05/20 Deutsche Bank Swatch Group price target raised to CHF 250 from CHF 245 at Deutsche Bank 09/17/20 Credit Suisse Swatch Group price target raised to CHF 280 from CHF 260 at Credit Suisse 09/10/20 Societe Generale Swatch Group upgraded to Hold from Sell at Societe Generale 09/10/20 Societe Generale Swatch Group upgraded to Hold from Sell at Societe Generale

2020-10-12 12:42:53

SWGAY

Swatch Group

$0.00 / + (+0.00%)

12:42

10/12/20

10/12

12:42

10/12/20

12:42

Swatch inventory risk 'not as bad as it looks,' says Credit Suisse

Credit Suisse analyst Guillaume Gauville reiterated an Outperform rating and CHF 280 price target on Swatch Group, saying the company's inventory risk is "not as bad as it looks." The analyst said he remains more constructive than the market on demand recovery, cost control, and inventory position.

SWGAY Swatch Group

$0.00 / + (+0.00%)

10/05/20 Deutsche Bank: Swatch Group price target raised to CHF 250 from CHF 245 at Deutsche Bank

09/17/20 Credit Suisse: Swatch Group price target raised to CHF 280 from CHF 260 at Credit Suisse

09/10/20 Societe Generale: Swatch Group upgraded to Hold from Sell at Societe Generale

09/10/20 Societe Generale: Swatch Group upgraded to Hold from Sell at Societe Generale

TODAY'S FREE FLY STORIES

Downgrade	Black Hills downgraded on additional leverage from Uri at Mizuho » 06:56 03/03/21 03/03 06:56 03/03/21 06:56 BKH Black Hills $59.94 / +0.03 (+0.05%) Mizuho analyst Paul… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events BKH Black Hills $59.94 / +0.03 (+0.05%) 03/01/21 Black Hills incurs $600M of additional natural gas costs from weather event 01/26/21 Black Hills gets approval for consolidation and rate increase in Nebraska 12/01/20 Black Hills completes 52.5-megawatt Corriedale wind energy project 11/05/20 Black Hills announces clean energy goals BKH Black Hills $59.94 / +0.03 (+0.05%) 06:29 Today Mizuho Black Hills downgraded to Neutral from Buy at Mizuho 12/15/20 Scotiabank Black Hills upgraded to Outperform on valuation at Scotiabank 12/15/20 Scotiabank Black Hills upgraded to Outperform from Sector Perform at Scotiabank 11/13/20 BofA Black Hills upgraded to Buy from Neutral at BofA BKH Black Hills $59.94 / +0.03 (+0.05%) 02/26/21 Black Hills backs FY21 EPS view $3.80-$4.00, consensus $3.90 02/09/21 Black Hills sees FY22 EPS $3.95 to $4.15 02/09/21 Black Hills raises FY21 EPS view $3.80-$4.00 from $3.75-$3.95, consensus $3.88 02/09/21 Black Hills reports Q4 EPS $1.23, consensus $1.15 04/27/21 Black Hills Corporation
Recommendations	Bentley Systems price target raised to $53 from $50 at Mizuho » 06:54 03/03/21 03/03 06:54 03/03/21 06:54 BSY Bentley Systems / + Mizuho analyst Matthew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options BSY Bentley Systems / + 11/10/20 Bentley Systems launches $100M corporate venture capital fund 10/19/20 Bentley Systems announces expanded alliance with Microsoft 10/19/20 Bentley Systems announces Chris Bradshaw as Chief Marketing Officer BSY Bentley Systems / + 01/12/21 Mizuho Bentley Systems price target raised to $50 from $44 at Mizuho 11/16/20 RBC Capital Bentley Systems upgraded to Outperform from Sector Perform at RBC Capital 10/19/20 Fly Intel: Top five analyst initiations 10/19/20 KeyBanc Bentley Systems initiated with a Sector Weight at KeyBanc BSY Bentley Systems / + 03/02/21 Bentley Systems sees FY21 revenue $895M-$920M, consensus $869.68M 03/02/21 Bentley Systems reports Q4 adjusted EPS 17c, consensus 16c 11/10/20 Bentley Systems sees FY20 revenues $790M- $800M, consensus $784.89M 11/10/20 Bentley Systems reports Q3 EPS 17c, consensus 13c 13 Nov 23 Sep BSY Bentley Systems / + 09/27/20 Opening Day: GoodRx rises over 50% in market debut BSY Bentley Systems / + 01/28/21 new option listings on January 28th
Downgrade	Adaptive Biotechnologies downgraded to Neutral from Buy at Goldman Sachs » 06:54 03/03/21 03/03 06:54 03/03/21 06:54 ADPT Adaptive Biotechnologies $53.11 / -4.75 (-8.21%) , RHHBY Roche $0.00 / + (+0.00%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events ADPT RHHBY ADPT Adaptive Biotechnologies $53.11 / -4.75 (-8.21%) 06:53 Today Adaptive says Genentech suspends development of shared antigen target candidate 02/23/21 Adaptive Biotechnologies expands collaboration with LabCorp 02/23/21 Adaptive Biotechnologies launches T-Detect COVID test 01/11/21 Adaptive in pact with AstraZeneca to investigate use of immunoSEQ T-MAP RHHBY Roche $0.00 / + (+0.00%) 06:53 Today Adaptive says Genentech suspends development of shared antigen target candidate 02/26/21 Regeneron announces CHMP recommendation for COVID-19 antibody cocktail 02/24/21 Prothena announces presentation of new preclinical PRX005 data 02/19/21 Atea Pharmaceuticals announces Chugai in-license of AT-527 from Roche ADPT RHHBY ADPT Adaptive Biotechnologies $53.11 / -4.75 (-8.21%) 01/19/21 BTIG Adaptive Biotechnologies price target raised to $74 from $66 at BTIG 12/17/20 BTIG BTIG positive on select healthcare diagnostic/tools names as '2021 Top Picks' 11/12/20 BTIG Adaptive Biotechnologies price target raised to $63 from $60 at BTIG 11/11/20 JPMorgan Adaptive Biotechnologies price target raised to $60 from $50 at JPMorgan RHHBY Roche $0.00 / + (+0.00%) 02/25/21 Berenberg Roche price target lowered to CHF 320 from CHF 325 at Berenberg 02/24/21 Morgan Stanley Roche price target lowered to CHF 345 from CHF 365 at Morgan Stanley 02/23/21 BofA BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list 02/17/21 UBS UBS downgrades Roche to Neutral on risk to 2022 estimates ADPT RHHBY ADPT Adaptive Biotechnologies $53.11 / -4.75 (-8.21%) 02/24/21 Adaptive Biotechnologies reports Q4 EPS (33c), consensus (29c) 11/10/20 Adaptive Biotechnologies reports Q3 EPS (27c), consensus (28c) RHHBY Roche $0.00 / + (+0.00%) 02/04/21 Roche reports 2020 core EPS CHF 19.16 vs. CHF 20.16 last year 10/27/20 Oncolytics announces new GI cancer study using 10/15/20 Roche confirms outlook for 2020 based on assessment of COVID-19 10/15/20 Roche reports 9 months group sales CHF43.98B vs. CHF46.07B last year 16 Jul RHHBY RHHBY Roche $0.00 / + (+0.00%) 02/11/21 Roche arthritis drug reduced Covid deaths in study, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports ADPT RHHBY ADPT Adaptive Biotechnologies $53.11 / -4.75 (-8.21%) 02/16/21 Fly Insider: Power REIT, Amphastar among week's notable insider trades 02/01/21 Fly Insider:Allied Esports,Applied Optoelectronics among notable insider trades 01/19/21 Fly Insider: REV Group, Neurocrine Bio among week's notable insider trades 12/14/20 Fly Insider: Molecular Templates, AMD among notable insider trades RHHBY Roche $0.00 / + (+0.00%) 12/26/20 Week in review: How Trump's policies moved stocks 11/30/20 Fly Intel: Wall Street's top stories for Monday 11/30/20 Fly Intel: Wall Street's top stories at midday 11/21/20 Week in review: How Trump's policies moved stocks 03/25/21 Roche - RHHBY
Upgrade	3D Systems upgraded to Hold from Sell at Loop Capital » 06:54 03/03/21 03/03 06:54 03/03/21 06:54 DDD 3D Systems $31.14 / -7.6 (-19.62%) Loop Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options DDD 3D Systems $31.14 / -7.6 (-19.62%) 03/02/21 3D Systems falls -14.8% 03/01/21 3D Systems sees FY21 gross margin 40%-44% 02/24/21 3D Systems announces introduction of High Speed Fusion 3D printing system 02/11/21 3D Systems selected by Raytheon and DEVCOM as part of research project DDD 3D Systems $31.14 / -7.6 (-19.62%) 05:34 Today Loop Capital 3D Systems upgraded to Hold from Sell at Loop Capital 01/29/21 Craig-Hallum 3D Systems downgraded to Hold from Buy at Craig-Hallum 01/29/21 Craig-Hallum 3D Systems downgraded to Hold from Buy at Craig-Hallum 01/25/21 Fly Intel: Top five analyst downgrades DDD 3D Systems $31.14 / -7.6 (-19.62%) 03/01/21 3D Systems reports Q4 EPS 9c, consensus 10c 03/01/21 Notable companies reporting after market close 01/07/21 3D Systems sees Q4 revenue $170M-$176M, consensus $139.91M. 11/05/20 3D Systems reports Q3 EPS (3c), consensus (8c) DDD 3D Systems $31.14 / -7.6 (-19.62%) 01/15/21 Accolade upgrade, Spotify downgrade among today's top calls on Wall Street 01/15/21 Fly Intel: Pre-market Movers 01/07/21 Fly Intel: Wall Street's top stories for Thursday 01/07/21 Fly Intel: Wall Street's top stories at midday 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference DDD 3D Systems $31.14 / -7.6 (-19.62%) 01/14/21 3D Systems call volume above normal and directionally bullish 01/07/21 3D Systems call volume above normal and directionally bullish 12/29/20 3D Systems put volume heavy and directionally bearish 12/17/20 3D Systems call volume above normal and directionally bullish
Hot Stocks	Boston Scientific to acquire surgical business of Lumenis for $1.07B » 06:53 03/03/21 03/03 06:53 03/03/21 06:53 BSX Boston Scientific $38.76 / -0.135 (-0.35%) Boston Scientific… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options BSX Boston Scientific $38.76 / -0.135 (-0.35%) 02/16/21 Appaloosa buys Macy's and Kohl's, exits AT&T in Q4 01/22/21 Boston Scientific's Vercise Genus Deep Brain Stimulation System approved by FDA 01/21/21 Boston Scientific to acquire Preventice Solutions for $925M in cash upfront 01/11/21 Boston Scientific announces Lotus Edge recall, sees $225M-$300M of charges BSX Boston Scientific $38.76 / -0.135 (-0.35%) 02/03/21 Piper Sandler Boston Scientific price target raised to $48 from $46 at Piper Sandler 02/01/21 Fly Intel: Top five analyst initiations 02/01/21 Deutsche Bank Boston Scientific initiated with a Hold at Deutsche Bank 01/25/21 Morgan Stanley iRhythm price target raised to $288 from $227 at Morgan Stanley BSX Boston Scientific $38.76 / -0.135 (-0.35%) 02/03/21 Boston Scientific reports Q4 adjusted EPS 23c, consensus 31c 02/02/21 Notable companies reporting before tomorrow's open 02/02/21 Notable companies reporting before tomorrow's open 01/12/21 Boston Scientific sees FY20 revenue $9.91B, consensus $10.08B 22 May BSX Boston Scientific $38.76 / -0.135 (-0.35%) 02/03/21 Fly Intel: Pre-market Movers 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday 01/12/21 Fly Intel: Pre-market Movers BSX Boston Scientific $38.76 / -0.135 (-0.35%) 02/25/21 Boston Scientific call volume above normal and directionally bullish 02/03/21 Unusually active option classes on open February 3rd 01/21/21 Boston Scientific call volume above normal and directionally bullish 10/14/20 Boston Scientific put volume heavy and directionally bearish

Upgrade	M3 Inc. upgraded to Buy from Neutral at Citi » 06:53 03/03/21 03/03 06:53 03/03/21 06:53 MTHRF M3 Inc. $0.00 / + (+0.00%) Citi analyst Hidemaru… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research MTHRF M3 Inc. $0.00 / + (+0.00%) 11/18/20 Credit Suisse M3 Inc. upgraded to Outperform from Neutral at Credit Suisse 08/19/20 Mizuho M3 Inc. upgraded to Buy from Neutral at Mizuho 04/07/20 Morgan Stanley M3 Inc. upgraded to Overweight from Equal Weight at Morgan Stanley
Hot Stocks	Adaptive says Genentech suspends development of shared antigen target candidate » 06:53 03/03/21 03/03 06:53 03/03/21 06:53 ADPT Adaptive Biotechnologies $53.11 / -4.75 (-8.21%) , RHHBY Roche $0.00 / + (+0.00%) In a regulatory filing… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events ADPT RHHBY ADPT Adaptive Biotechnologies $53.11 / -4.75 (-8.21%) 02/23/21 Adaptive Biotechnologies expands collaboration with LabCorp 02/23/21 Adaptive Biotechnologies launches T-Detect COVID test 01/11/21 Adaptive in pact with AstraZeneca to investigate use of immunoSEQ T-MAP 12/06/20 Adaptive announces new data demonstrating impact of clonoSEQ Assay RHHBY Roche $0.00 / + (+0.00%) 02/26/21 Regeneron announces CHMP recommendation for COVID-19 antibody cocktail 02/24/21 Prothena announces presentation of new preclinical PRX005 data 02/19/21 Atea Pharmaceuticals announces Chugai in-license of AT-527 from Roche 02/12/21 Genentech announces results from four Phase III studies of faricimab ADPT RHHBY ADPT Adaptive Biotechnologies $53.11 / -4.75 (-8.21%) 01/19/21 BTIG Adaptive Biotechnologies price target raised to $74 from $66 at BTIG 12/17/20 BTIG BTIG positive on select healthcare diagnostic/tools names as '2021 Top Picks' 11/12/20 BTIG Adaptive Biotechnologies price target raised to $63 from $60 at BTIG 11/11/20 JPMorgan Adaptive Biotechnologies price target raised to $60 from $50 at JPMorgan RHHBY Roche $0.00 / + (+0.00%) 02/25/21 Berenberg Roche price target lowered to CHF 320 from CHF 325 at Berenberg 02/24/21 Morgan Stanley Roche price target lowered to CHF 345 from CHF 365 at Morgan Stanley 02/23/21 BofA BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list 02/17/21 UBS UBS downgrades Roche to Neutral on risk to 2022 estimates ADPT RHHBY ADPT Adaptive Biotechnologies $53.11 / -4.75 (-8.21%) 02/24/21 Adaptive Biotechnologies reports Q4 EPS (33c), consensus (29c) 11/10/20 Adaptive Biotechnologies reports Q3 EPS (27c), consensus (28c) RHHBY Roche $0.00 / + (+0.00%) 02/04/21 Roche reports 2020 core EPS CHF 19.16 vs. CHF 20.16 last year 10/27/20 Oncolytics announces new GI cancer study using 10/15/20 Roche confirms outlook for 2020 based on assessment of COVID-19 10/15/20 Roche reports 9 months group sales CHF43.98B vs. CHF46.07B last year 16 Jul RHHBY RHHBY Roche $0.00 / + (+0.00%) 02/11/21 Roche arthritis drug reduced Covid deaths in study, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports ADPT RHHBY ADPT Adaptive Biotechnologies $53.11 / -4.75 (-8.21%) 02/16/21 Fly Insider: Power REIT, Amphastar among week's notable insider trades 02/01/21 Fly Insider:Allied Esports,Applied Optoelectronics among notable insider trades 01/19/21 Fly Insider: REV Group, Neurocrine Bio among week's notable insider trades 12/14/20 Fly Insider: Molecular Templates, AMD among notable insider trades RHHBY Roche $0.00 / + (+0.00%) 12/26/20 Week in review: How Trump's policies moved stocks 11/30/20 Fly Intel: Wall Street's top stories for Monday 11/30/20 Fly Intel: Wall Street's top stories at midday 11/21/20 Week in review: How Trump's policies moved stocks 03/25/21 Roche - RHHBY
Initiation	Natixis resumed with a Buy at Citi » 06:51 03/03/21 03/03 06:51 03/03/21 06:51 NTXFY Natixis $0.00 / + (+0.00%) Citi analyst Azzurra… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research NTXFY Natixis $0.00 / + (+0.00%) 02/10/21 BPCE intends to file tender offer for remaining Natixis shares at EUR 4 NTXFY Natixis $0.00 / + (+0.00%) 02/10/21 RBC Capital Natixis downgraded to Sector Perform from Outperform at RBC Capital 02/10/21 Societe Generale Natixis upgraded to Hold from Sell at Societe Generale 01/27/21 Societe Generale Natixis downgraded to Sell from Hold at Societe Generale 01/07/21 Credit Suisse Natixis downgraded to Underperform from Neutral at Credit Suisse
Hot Stocks	Eli Lilly, Incyte announce BRAVE-AA2 study met primary endpoint » 06:51 03/03/21 03/03 06:51 03/03/21 06:51 LLY Eli Lilly $204.13 / -2.26 (-1.10%) , INCY Incyte $78.57 / -1.12 (-1.41%) Eli Lilly (LLY) and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LLY INCY LLY Eli Lilly $204.13 / -2.26 (-1.10%) 02/26/21 Eli Lilly awarded $210M Army contract for 100,000 doses of antibody therapeutic 02/26/21 Eli Lilly awarded $2.52B Army contract for LY-CoV555, LY-CoV016 02/26/21 Eli Lilly: Additional doses of neutralizing antibody therapy purchased by U.S. 02/25/21 Eli Lilly, Welldoc announce agreement to create insulin management solution INCY Incyte $78.57 / -1.12 (-1.41%) 02/26/21 Incyte announces EMA validation of retifanlimab MAA 02/22/21 Incyte announces FDA acceptance, priority review for ruxolitinib sNDA 02/19/21 Incyte announces acceptance, priority review for ruxolitinib cream NDA 02/09/21 Incyte sees FY21 Jakafi revenue $2.13B-$2.2B LLY INCY LLY Eli Lilly $204.13 / -2.26 (-1.10%) 03/02/21 JPMorgan Eli Lilly risk/reward favorable into Alzheimer's data, says JPMorgan 02/18/21 H.C. Wainwright Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright 02/18/21 Piper Sandler Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler 02/12/21 Cowen Eli Lilly price target raised to $235 from $195 at Cowen INCY Incyte $78.57 / -1.12 (-1.41%) 02/10/21 SVB Leerink Incyte downgraded to Market Perform from Outperform at SVB Leerink 01/07/21 Truist Incyte initiated with a Buy at Truist 01/07/21 Truist Incyte initiated with a Buy at Truist 01/04/21 Guggenheim Incyte upgraded to Buy from Neutral at Guggenheim LLY INCY LLY Eli Lilly $204.13 / -2.26 (-1.10%) 01/29/21 Eli Lilly backs FY21 EPS view $7.75-$8.40, consensus $8.20 01/29/21 Eli Lilly reports Q4 EPS $2.75, consensus $2.35 01/28/21 Notable companies reporting before tomorrow's open 01/28/21 Notable companies reporting before tomorrow's open INCY Incyte $78.57 / -1.12 (-1.41%) 02/09/21 Incyte reports Q4 EPS 93c, consensus 75c 02/08/21 Notable companies reporting before tomorrow's open 02/08/21 Notable companies reporting before tomorrow's open 11/05/20 Incyte reports Q3 EPS 23c, consensus 75c LLY LLY Eli Lilly $204.13 / -2.26 (-1.10%) 02/10/21 Eli Lilly won't try to claw back past pay from former CFO Smiley, WSJ reports 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says LLY INCY LLY Eli Lilly $204.13 / -2.26 (-1.10%) 02/09/21 Fly Intel: Wall Street's top stories for Tuesday 02/09/21 Fly Intel: Wall Street's top stories at midday 01/29/21 Fly Intel: Wall Street's top stories for Friday 01/29/21 Fly Intel: Wall Street's top stories at midday INCY Incyte $78.57 / -1.12 (-1.41%) 02/09/21 Fly Intel: Pre-market Movers 03/05/21 Healthcare 03/02/21 41st Annual Healthcare Virtual Conference 03/10/21 Global Healthcare Virtual Conference 2021 03/15/21 Eli Lilly - LLY 04/27/21 Eli Lilly - LLY 06/21/21 PDUFA Date for Ruxolitinib Cream 06/22/21 PDUFA Date for Jakafi (ruxolitinib) sNDA for GVHD 07/25/21 PDUFA Date for Retifanlimab LLY INCY LLY Eli Lilly $204.13 / -2.26 (-1.10%) 01/15/21 Eli Lilly call volume above normal and directionally bullish 01/13/21 Early notable gainers among liquid option names on January 13th 01/11/21 Early notable gainers among liquid option names on January 11th 12/09/20 Early notable gainers among liquid option names on December 9th INCY Incyte $78.57 / -1.12 (-1.41%) 01/22/21 Early notable gainers among liquid option names on January 22nd 12/14/20 Early notable gainers among liquid option names on December 14th
Earnings	OneSpaWorld reports Q4 EPS (33c), consensus (21c) » 06:48 03/03/21 03/03 06:48 03/03/21 06:48 OSW OneSpaWorld $11.54 / +0.16 (+1.41%) Reports Q4 revenue $3.8M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events OSW OneSpaWorld $11.54 / +0.16 (+1.41%) 10/30/20 OneSpaWorld rises after CDC lifts no sail order with conditions 09/16/20 OneSpaWorld CEO sets retirement date, Bonner named CCO OSW OneSpaWorld $11.54 / +0.16 (+1.41%) 01/13/21 Jefferies OneSpaWorld downgraded to Hold at Jefferies following over 50% rally 01/13/21 Jefferies OneSpaWorld downgraded to Hold from Buy at Jefferies 10/30/20 Stifel CDC lifting 'no sail order' a 'clear positive' for cruise liners, says Stifel 06/09/20 Stifel OneSpaWorld price target raised to $10 from $7 at Stifel OSW OneSpaWorld $11.54 / +0.16 (+1.41%) 11/10/20 OneSpaWorld reports Q3 EPS (26c), consensus (25c) 10:00 Today OneSpaWorld - OSW

Downgrade	PNM Resources downgraded to Neutral from Buy at Citi » 06:48 03/03/21 03/03 06:48 03/03/21 06:48 PNM PNM Resources $47.66 / -0.385 (-0.80%) Citi analyst Ryan Levine… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings PNM PNM Resources $47.66 / -0.385 (-0.80%) 02/12/21 PNM Resources investors 'overwhelmingly' approve AVANGRID deal 02/12/21 PNM Resources shareholders approve merger with Avangrid 02/02/21 Avangrid receives clearance from CFIUS for proposed PNM Resources merger 01/27/21 Avangrid says Hart-Scott-Rodino waiting period expired for PNM merger PNM PNM Resources $47.66 / -0.385 (-0.80%) 01/06/21 Wells Fargo PNM Resources downgraded to Underweight from Equal Weight at Wells Fargo 11/18/20 Fly Intel: Top five analyst downgrades 11/18/20 Barclays PNM Resources downgraded to Underweight from Equal Weight at Barclays 10/26/20 UBS PNM Resources downgraded to Neutral from Buy at UBS PNM PNM Resources $47.66 / -0.385 (-0.80%) 12/17/20 PNM Resources sees FY21 ongoing EPS $2.27-$2.37, consensus $2.33 12/17/20 PNM Resources backs FY20 ongoing EPS view $2.23-$2.31, consensus $2.28 10/30/20 PNM Resources backs FY20 ongoing EPS view $2.23-$2.31, consensus $2.24 10/30/20 PNM Resources reports Q3 ongoing EPS $1.40, consensus $1.26
Hot Stocks	Junshi, Coherus BioSciences initiate rolling submission of BLA for toripalimab » 06:48 03/03/21 03/03 06:48 03/03/21 06:48 CHRS Coherus Biosciences $15.69 / -0.38 (-2.36%) Junshi Biosciences and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CHRS Coherus Biosciences $15.69 / -0.38 (-2.36%) 02/17/21 Coherus Biosciences announces acceptance of BLA filing for CHS-1420 02/16/21 Coherus CFO Jean-Frederic Viret to resign 02/02/21 Coherus Biosciences to receive $50M strategic investment 02/01/21 Coherus Biosciences, Junshi Biosciences collaborate to co-develop toripalimab CHRS Coherus Biosciences $15.69 / -0.38 (-2.36%) 02/25/21 Citi Coherus Biosciences price target lowered to $27 from $30 at Citi 02/25/21 H.C. Wainwright Coherus Biosciences price target lowered to $29 from $33 at H.C. Wainwright 11/19/20 Mizuho Coherus Biosciences price target lowered to $30 from $35 at Mizuho 08/21/20 Mizuho Express Scripts exclusion does not impact Coherus, says Mizuho CHRS Coherus Biosciences $15.69 / -0.38 (-2.36%) 11/05/20 Coherus Biosciences reports Q3 EPS 47c, consensus 41c
Recommendations	Cinemark price target raised to $30 from $21 at Benchmark » 06:48 03/03/21 03/03 06:48 03/03/21 06:48 CNK Cinemark $23.87 / -0.06 (-0.25%) Benchmark analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CNK Cinemark $23.87 / -0.06 (-0.25%) 02/22/21 Movie theater operators jump as Gov. Cuomo gives greenlight to NYC reopening 12/22/20 Sony Pictures CEO says 'don't think' will move to 'day and date' film releases 12/03/20 Warner Bros. to release 2021 films in theaters, on HBO Max simultaneously 12/03/20 Warner Bros. to release films in theaters and on HBO Max simultaneously in 2021 CNK Cinemark $23.87 / -0.06 (-0.25%) 02/23/21 Wedbush Cinemark price target raised to $28 from $15 at Wedbush 02/01/21 MKM Partners Cinemark downgraded to Neutral from Buy at MKM Partners 02/01/21 MKM Partners Cinemark downgraded to Neutral from Buy at MKM Partners 01/25/21 Goldman Sachs Cinemark price target raised to $16 from $11 at Goldman Sachs CNK Cinemark $23.87 / -0.06 (-0.25%) 02/26/21 Cinemark reports Q4 EPS ($2.03), consensus ($1.46) 02/25/21 Notable companies reporting before tomorrow's open 02/25/21 Notable companies reporting before tomorrow's open 11/05/20 Cinemark reports Q3 EPS ($1.25), consensus ($1.33) CNK Cinemark $23.87 / -0.06 (-0.25%) 02/22/21 Movie theaters might get OK to reopen in New York City, Deadline says 12/03/20 Cinemark says Warner Bros. hasn't given details on 2021 plan, Bloomberg reports 10/18/20 NY state moves to reopen movie theaters, ski resorts, Bloomberg reports CNK Cinemark $23.87 / -0.06 (-0.25%) 02/26/21 Fly Intel: Pre-market Movers 12/28/20 AMC, Cinemark rise as WW84 scores highest box office opening of pandemic 12/14/20 Fly Intel: Wall Street's top stories for Monday 12/14/20 Cinemark, AMC slip after denying M&A discussions 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference CNK Cinemark $23.87 / -0.06 (-0.25%) 02/25/21 Cinemark put volume heavy and directionally bearish 02/10/21 Cinemark call volume above normal and directionally bullish 01/19/21 Cinemark put volume heavy and directionally bearish 12/09/20 Cinemark put volume heavy and directionally bearish
Recommendations	Clover Health price target lowered to $13 from $19 at Citi » 06:47 03/03/21 03/03 06:47 03/03/21 06:47 CLOV Clover Health $9.04 / -1.35 (-12.99%) Citi analyst Ralph… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Options CLOV Clover Health $9.04 / -1.35 (-12.99%) 02/16/21 Greenlight Capital buys FuboTV and Danimer Scientific, exits Intel 02/05/21 Palihapitiya calls Hindenburg's comments on Clover 'spurious' 02/05/21 Clover Health receives letter from SEC on investigation after Hindenburg article 02/05/21 Clover Health says short seller firm's 'rife' with 'sweeping inaccuracies' CLOV Clover Health $9.04 / -1.35 (-12.99%) 02/02/21 Fly Intel: Top five analyst initiations 02/02/21 Citi Clover Health initiated with a Buy at Citi 02/01/21 JPMorgan Clover Health initiated with a Neutral at JPMorgan CLOV Clover Health $9.04 / -1.35 (-12.99%) 02/05/21 Hindenburg, in Clover response, says regular investors shouldn't be last to know CLOV Clover Health $9.04 / -1.35 (-12.99%) 02/05/21 Fly Intel: Wall Street's top stories for Friday 02/05/21 Fly Intel: Wall Street's top stories at midday 02/04/21 Fly Intel: Wall Street's top stories for Thursday 02/04/21 Fly Intel: Wall Street's top stories at midday CLOV Clover Health $9.04 / -1.35 (-12.99%) 03/01/21 Clover Health call volume above normal and directionally bullish 01/25/21 Unusually active option classes on open January 25th 01/13/21 Diagonal spread in Clover Health rolls short January calls out and up 01/08/21 Two new option listings and four option delistings on January 8th
Recommendations	Nutanix estimates raised as several drivers seen, says Susquehanna » 06:46 03/03/21 03/03 06:46 03/03/21 06:46 NTNX Nutanix $29.93 / -0.795 (-2.59%) Susquehanna analyst Mehdi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options NTNX Nutanix $29.93 / -0.795 (-2.59%) 12/29/20 VMware initiates legal proceedings against former COO for breach of contract 12/09/20 Nutanix appoints Rajiv Ramaswami as CEO 09/08/20 Nutanix rallies after inking new cloud partnership with Microsoft 09/08/20 Nutanix partners with Microsoft Azure for hybrid solution NTNX Nutanix $29.93 / -0.795 (-2.59%) 02/25/21 KeyBanc Nutanix price target raised to $42 from $37 at KeyBanc 02/25/21 Wells Fargo Nutanix price target raised to $40 from $35 at Wells Fargo 02/25/21 Needham Nutanix price target raised to $43 from $37 at Needham 01/13/21 William Blair VMware downgraded to Market Perform at William Blair after executive exits NTNX Nutanix $29.93 / -0.795 (-2.59%) 02/24/21 Nutanix sees Q3 ACV Billings $150M-$155M 02/24/21 Nutanix reports Q2 adjusted EPs (37c), consensus (48c) 02/24/21 Notable companies reporting after market close 11/23/20 Nutanix reports Q1 adjusted EPS (44c), consensus (57c) NTNX Nutanix $29.93 / -0.795 (-2.59%) 02/24/21 Fly Intel: After-Hours Movers 01/13/21 VMware slides as Gelsinger returns to Intel to be new CEO 11/23/20 Fly Intel: After-Hours Movers 09/08/20 Fly Intel: Wall Street's top stories for Tuesday 03/09/21 Nutanix NTNX Nutanix $29.93 / -0.795 (-2.59%) 01/28/21 Nutanix put volume heavy and directionally bearish 01/27/21 Nutanix put volume heavy and directionally bearish 11/23/20 Nutanix options imply 18.4% move in share price post-earnings 11/10/20 Nutanix put volume heavy and directionally bearish

Recommendations	Niu Technologies price target raised to $48 from $37 at Citi » 06:46 03/03/21 03/03 06:46 03/03/21 06:46 NIU Niu Technologies $38.28 / -2.08 (-5.15%) Citi analyst Beatrice Lam… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Events Options NIU Niu Technologies $38.28 / -2.08 (-5.15%) 12/07/20 Aurora Mobile, Niu Technologies enter partnership agreement 10/09/20 Niu Technologies reports Q3 e-scooter sales of 250,889 NIU Niu Technologies $38.28 / -2.08 (-5.15%) 01/15/21 Needham Niu Technologies price target raised to $46 from $36 at Needham 11/06/20 Citi Niu Technologies upgraded to Buy from Neutral at Citi 10/12/20 Piper Sandler Niu Technologies price target raised to $31 from $25 at Piper Sandler 08/17/20 Citi Niu Technologies downgraded to Neutral from Buy at Citi 03/08/21 Niu Technologies - NIU 03/09/21 Niu Technologies NIU Niu Technologies $38.28 / -2.08 (-5.15%) 02/17/21 Niu Technologies call volume above normal and directionally bullish 01/15/21 Niu Technologies put volume heavy and directionally bearish 12/03/20 Largest borrow rate increases among liquid names 11/25/20 Niu Technologies call volume above normal and directionally bullish
General news	FX Action: Broad weakness in the Japanese currency has maintained buoyancy in USD-JPY » 06:45 03/03/21 03/03 06:45 03/03/21 06:45 FX Action: Broad weakness… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
General news	Week of 2/26 MBA Mortgage Applications to be released at 07:00 06:45 03/03/21 03/03 06:45 03/03/21 06:45
Recommendations	21Vianet price target raised to $47 from $33 at Citi » 06:43 03/03/21 03/03 06:43 03/03/21 06:43 VNET 21Vianet $37.43 / -1.305 (-3.37%) Citi analyst Arthur Lai… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events VNET 21Vianet $37.43 / -1.305 (-3.37%) 11/24/20 21Vianet reports Q3 cabinets under management 51,476 VNET 21Vianet $37.43 / -1.305 (-3.37%) 11/04/20 Daiwa 21Vianet initiated with a Buy at Daiwa 09/28/20 BofA 21Vianet initiated with a Buy at BofA 09/28/20 BofA 21Vianet initiated with a Buy at BofA 07/14/20 UBS 21Vianet initiated with a Buy at UBS VNET 21Vianet $37.43 / -1.305 (-3.37%) 11/24/20 21Vianet reports Q3 EPS 2c, consensus (3c) 26 Aug 05 Mar VNET 21Vianet $37.43 / -1.305 (-3.37%) 01/20/21 Fly Intel: After-Hours Movers 11/25/20 Fly Intel: Pre-market Movers 11/24/20 Fly Intel: After-Hours Movers 03/23/21 21Vianet - VNET
Recommendations	Mayville Engineering results suggest volume recovery continues, says Baird » 06:42 03/03/21 03/03 06:42 03/03/21 06:42 MEC Mayville Engineering $15.15 / +0.44 (+2.99%) Baird analyst Mircea… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events MEC Mayville Engineering $15.15 / +0.44 (+2.99%) 03/02/21 Mayville Engineering not providing financial outlook for 2021 11/02/20 Mayville Engineering is not providing financial outlook MEC Mayville Engineering $15.15 / +0.44 (+2.99%) 02/04/21 Baird Mayville Engineering price target raised to $20 from $14 at Baird 11/04/20 Citi Mayville Engineering price target raised to $13 from $10 at Citi 08/21/20 Fly Intel: Top five analyst upgrades 08/21/20 UBS Mayville Engineering upgraded to Buy from Neutral at UBS MEC Mayville Engineering $15.15 / +0.44 (+2.99%) 03/02/21 Mayville Engineering reports Q4 pro forma EPS 5c, consensus 1c 11/02/20 Mayville Engineering reports Q3 pro forma EPS (5c), consensus (4c) 10:00 Today Mayville Engineering - MEC

Hot Stocks	Stellantis sees 2021 adjusted operating income margin of 5.5%-7.5% 06:42 03/03/21 03/03 06:42 03/03/21 06:42 STLA Stellantis $17.00 / +0.13 (+0.77%) ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Events STLA Stellantis $17.00 / +0.13 (+0.77%) 06:42 Today Stellantis: Fiat Chrysler reports 2020 adjusted net profit EUR1.86B 05:12 Today Stellantis announces $8,010 2020 profit sharing payment to UAW employees 02/17/21 EU passenger car registrations down 24.0% in January 01/27/21 FCA US to pay $30M to resolve investigation involving National Training Center STLA Stellantis $17.00 / +0.13 (+0.77%) 03/02/21 AlphaValue Stellantis upgraded to Buy from Add at AlphaValue 02/24/21 Fly Intel: Top five analyst initiations 02/24/21 Citi Stellantis resumed with a Buy at Citi 02/10/21 Morgan Stanley Renault downgraded to Equal Weight from Overweight at Morgan Stanley STLA Stellantis $17.00 / +0.13 (+0.77%) 02/23/21 Stellantis CEO says car production costs in Italy are higher, Reuters says 02/02/21 'Apple Car' to use E-GMP platform from Hyundai, Apple Insider reports STLA Stellantis $17.00 / +0.13 (+0.77%) 02/02/21 Dell, Palo Alto upgrades among today's top calls on Wall Street 09:30 Today Stellantis - STLA
Recommendations	Citi boosts Micron target to $116, still sees $150 stock longer term » 06:42 03/03/21 03/03 06:42 03/03/21 06:42 MU Micron $91.02 / -3.74 (-3.95%) Citi analyst Christopher… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MU Micron $91.02 / -3.74 (-3.95%) 02/18/21 Micron's Poppen sells 46,554 common shares 02/16/21 Appaloosa buys Macy's and Kohl's, exits AT&T in Q4 01/26/21 Micron announces volume shipment of 1-alpha node DRAM products 01/14/21 Micron director sells 50K shares of common stock MU Micron $91.02 / -3.74 (-3.95%) 03/02/21 Evercore ISI Micron price target raised to $135 from $105 at Evercore ISI 03/01/21 Wedbush Micron price target raised to $100 from $88 at Wedbush 03/01/21 Barclays Micron price target raised to $110 from $100 at Barclays 02/25/21 Mizuho Micron price target raised to $100 from $85 at Mizuho MU Micron $91.02 / -3.74 (-3.95%) 01/07/21 Micron sees Q2 EPS 75c +/- 7c, consensus 63c 01/07/21 Micron reports Q1 EPS 78c, consensus 71c 01/07/21 Notable companies reporting after market close 12/01/20 Micron raises Q1 adj. EPS view 69c-73c from 40c-54c, consensus 48c MU Micron $91.02 / -3.74 (-3.95%) 02/24/21 Biden to address chip shortages with executive action, WSJ reports 02/11/21 Biden administration called on by chip industry to fund factories, Reuters says 12/04/20 Micron fab power outage may impact global DRAM supply, DigiTimes reports 12/03/20 U.S. in talks with Huawei CFO to settle charges, WSJ reports MU Micron $91.02 / -3.74 (-3.95%) 03/02/21 Zoom Video, TripAdvisor upgrades among today's top calls 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 03/31/21 Micron - MU MU Micron $91.02 / -3.74 (-3.95%) 02/26/21 Micron call volume above normal and directionally bullish 01/20/21 Micron call buyer realizes 56% same-day gains 01/07/21 Micron options imply 9.7% move in share price post-earnings 01/05/21 Micron call volume above normal and directionally bullish
Hot Stocks	Stellantis: Fiat Chrysler reports 2020 adjusted net profit EUR1.86B » 06:42 03/03/21 03/03 06:42 03/03/21 06:42 STLA Stellantis $17.00 / +0.13 (+0.77%) Fiat Chrysler reported… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Events STLA Stellantis $17.00 / +0.13 (+0.77%) 05:12 Today Stellantis announces $8,010 2020 profit sharing payment to UAW employees 02/17/21 EU passenger car registrations down 24.0% in January 01/27/21 FCA US to pay $30M to resolve investigation involving National Training Center STLA Stellantis $17.00 / +0.13 (+0.77%) 03/02/21 AlphaValue Stellantis upgraded to Buy from Add at AlphaValue 02/24/21 Fly Intel: Top five analyst initiations 02/24/21 Citi Stellantis resumed with a Buy at Citi 02/10/21 Morgan Stanley Renault downgraded to Equal Weight from Overweight at Morgan Stanley STLA Stellantis $17.00 / +0.13 (+0.77%) 02/23/21 Stellantis CEO says car production costs in Italy are higher, Reuters says 02/02/21 'Apple Car' to use E-GMP platform from Hyundai, Apple Insider reports STLA Stellantis $17.00 / +0.13 (+0.77%) 02/02/21 Dell, Palo Alto upgrades among today's top calls on Wall Street 09:30 Today Stellantis - STLA
Syndicate	VICI Properties files to sell 60M shares of common stock » 06:41 03/03/21 03/03 06:41 03/03/21 06:41 VICI VICI Properties $28.63 / -0.3 (-1.04%) Morgan Stanley, BofA… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events VICI VICI Properties $28.63 / -0.3 (-1.04%) 06:38 Today VICI Properties to acquire Venetian Resort's real estate in Las Vegas for $4B 06:34 Today Las Vegas Sands to sell The Venetian, other Las Vegas properties for $6.25B 06:34 Today Apollo Global funds to acquire The Venetian Resort and Sands Expo for $2.25B 12/24/20 VICI Properties enters triple-net lease agreement with EBCI VICI VICI Properties $28.63 / -0.3 (-1.04%) 02/22/21 Deutsche Bank VICI Properties price target raised to $32 from $28 at Deutsche Bank 01/26/21 Goldman Sachs VICI Properties price target raised to $33 from $27 at Goldman Sachs 12/17/20 JPMorgan VICI Properties initiated with an Overweight at JPMorgan 12/16/20 Baird VICI Properties reinstated with an Outperform at Baird VICI VICI Properties $28.63 / -0.3 (-1.04%) 02/18/21 VICI Properties reports Q4 EPS 53c, consensus 48c 02/18/21 VICI Properties sees FY21 AFFO per share $1.82-$1.87, consensus $1.88 02/18/21 VICI Properties reports Q4 AFFO per share 46c, consensus 47c 10/28/20 VICI Properties reports Q3 adjusted FFO 43c, consensus 42c 17 Jun 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference
Recommendations	B&G Foods price target lowered to $29 from $32 at RBC Capital » 06:41 03/03/21 03/03 06:41 03/03/21 06:41 BGS B&G Foods $30.44 / -0.36 (-1.17%) RBC Capital analyst Nik… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options BGS B&G Foods $30.44 / -0.36 (-1.17%) 02/16/21 Cooperman's Omega Advisors buys GM, exits Lee in Q4 12/23/20 B&G Foods recalls individual containers of Food Club Garlic Powder 12/01/20 B&G Foods sees accretion from acquisition of J. M. Smucker's Crisco oils 11/16/20 B&G Foods CEO Kenneth Romanzi to step aside, David Wenner named interim CEO BGS B&G Foods $30.44 / -0.36 (-1.17%) 01/19/21 Stephens B&G Foods initiated with an Equal Weight at Stephens 01/05/21 Credit Suisse B&G Foods downgraded to Underperform from Neutral at Credit Suisse 07/28/20 Seaport Global B&G Foods initiated with a Neutral at Seaport Global 06/12/20 Fly Intel: Top five analyst initiations BGS B&G Foods $30.44 / -0.36 (-1.17%) 03/02/21 B&G Foods sees FY21 revenue roughly $2.05B-$2.1B, consensus $2.03B 03/02/21 B&G Foods reports Q4 adjusted EPS 35c, consensus 44c 11/16/20 B&G Foods backs FY20 adjusted EPS view $2.30-$2.40, consensus $2.33 11/05/20 B&G Foods sees FY20 adjusted EPS $2.30-$2.40, consensus $2.22 BGS B&G Foods $30.44 / -0.36 (-1.17%) 03/02/21 Fly Intel: After-Hours Movers 10/26/20 Fly Intel: After-Hours Movers 03/04/21 B&G Foods BGS B&G Foods $30.44 / -0.36 (-1.17%) 01/22/21 Largest borrow rate increases among liquid names 12/28/20 Largest borrow rate increases among liquid names 12/08/20 Largest borrow rate increases among liquid names 11/25/20 Largest borrow rate increases among liquid names

Events

Earnings calls, analyst events, roadshows and more

Today at 07:00

MBA Mortgage Applications: Purchase Index W/W: 2/26/2021 Government Event
Today at 07:00

MBA Mortgage Applications: Refinance Index W/W: 2/26/2021 Government Event
Today at 07:00

MBA Mortgage Applications: Composite Index W/W: 2/26/2021 Government Event
TSHA
Today at 08:00

Taysha Gene Therapies - TSHA Conference Calls
OPTN
Today at 08:00

Optinose - OPTN Conference Calls
BQ
Today at 08:00

Boqii - BQ Conference Calls
ISEE
Today at 08:00

Iveric bio - ISEE Conference Calls
Today at 08:15

ADP Employment Report: Private Payrolls M/M: February 2021 Government Event
SBBP
Today at 08:30

Strongbridge Biopharma - SBBP Conference Calls
WEN
Today at 08:30

Wendy's - WEN Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 16M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer $9.14 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel $29.00-30.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson $45.99 4.5M Shares DGII X DGII Digi International Secondary Managers: Piper Sandler $23.46 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton $32.22 10.6M Shares
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham $35.91 4M Shares
Fri	No deals

View All Syndicate Announcements »

Swatch inventory risk 'not as bad as it looks,' says Credit Suisse

TODAY'S FREE FLY STORIES

Get Full Fly Access